- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patent holdings for IPC class C07D 513/00
Total number of patents in this class: 116
10-year publication summary
|
3
|
3
|
2
|
1
|
3
|
1
|
4
|
3
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3736 |
5 |
| Bristol-myers Squibb Company | 4751 |
4 |
| Boehringer Ingelheim International GmbH | 4493 |
3 |
| SpecGx LLC | 186 |
3 |
| Glaxo Group Limited | 4360 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Janssen Pharmaceutica N.V. | 3162 |
2 |
| Wyeth LLC | 605 |
2 |
| Amgen Inc. | 4429 |
2 |
| Merck Sharp & Dohme B.V. | 914 |
2 |
| Abbvie Inc. | 1824 |
2 |
| Progenics Pharmaceuticals, Inc. | 123 |
2 |
| Novartis AG | 10251 |
1 |
| F. Hoffmann-La Roche AG | 7819 |
1 |
| Samsung Display Co., Ltd. | 38676 |
1 |
| The Regents of the University of California | 20778 |
1 |
| Genentech, Inc. | 4110 |
1 |
| Pfizer Inc. | 3396 |
1 |
| Merck Patent GmbH | 5729 |
1 |
| Bayer Animal Health GmbH | 173 |
1 |
| Other owners | 77 |